Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles

International Journal of Pharmaceutics

Volumn 404, Issue 1-2, 2011, Pages 75-82

  Klose, D ^a,b,c   Delplace, C ^a,b   Siepmann, J ^a,b  

^a UNIV LILLE   (France)

^b France   (France)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Controlled release; Microparticles; PLGA; Release conditions; Sink conditions

Indexed keywords

CARBAMAZEPINE; IBUPROFEN; POLYGLACTIN; RESOMER RG 504H; UNCLASSIFIED DRUG;

ARTICLE; DRUG DEGRADATION; DRUG RELEASE; EVAPORATION; GLASS TRANSITION TEMPERATURE; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLVENT EXTRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; HYDROGEN-ION CONCENTRATION; IBUPROFEN; KINETICS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYGLYCOLIC ACID; POROSITY; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TRANSITION TEMPERATURE;

EID: 78650678085     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.10.054     Document Type: Article

References (42)

1. J.M. Anderson, and M.S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Del. Rev. 28 1997 5 24
2. A. Aubert-Pouëssel, D.C. Bibby, M.C. Venier-Julienne, F. Hindré, and J.P. Benoit A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres Pharm. Res. 19 2002 1046 1051
3. D.F. Bain, D.L. Munday, and A. Smith Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(dl-lactide) J. Microencapsul. 16 1999 369 385
4. C. Berkland, K. Kim, and D.W. Pack PLG microsphere size controls drug release rate through several competing factors Pharm. Res. 20 2003 1055 1062
5. A. Brunner, K. Maeder, and A. Goepferich pH and osmotic pressure inside biodegradable microspheres during erosion Pharm. Res. 16 1999 847 853
6. D. Burgess, D. Crommelin, A. Hussain, and M. Chen Assuring quality and performance of sustained and controlled release parenterals Eur. J. Pharm. Sci. 21 2004 679 690
7. D. Burgess, A.S. Hussain, T.S. Ingallinera, and M.L. Chen Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP Pharm. Res. 19 2002 1761 1768
8. C.B. Conti, I. Genta, P. Giunchedi, and T. Modena Testing of "in vitro" dissolution behaviour of microparticulate drug delivery systems Drug Dev. Ind. Pharm. 21 1995 1223 1233
9. S. D'Souza, and P.P. DeLuca Methods to assess in vitro drug release from injectable polymeric particulate systems Pharm. Res. 23 2006 460 474
10. S. D'Souza, and P.P. DeLuca Development of a dialysis in vitro release method for biodegradable microspheres AAPS PharmSciTech 6 2005 323 328
11. M. Dunne, O.I. Corrigan, and Z. Ramtoola Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles Biomaterials 21 2000 1659 1668
12. N. Faisant, J. Akiki, F. Siepmann, J.P. Benoit, and J. Siepmann Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory Int. J. Pharm. 314 2006 189 197
13. E. Fournier, C. Passirani, C.N. Montero-Menei, and J.P. Benoit Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility Biomaterials 24 2003 3311 3331
14. A. Frank, S.K. Rath, and S.S. Venkatraman Controlled release from bioerodible polymers: effect of drug type and polymer composition J. Control. Release 102 2005 333 344
15. S. Freiberg, and X.X. Zhu Polymer microspheres for controlled drug release Int. J. Pharm. 282 2004 1 18
16. K. Fu, D.W. Pack, A.M. Klibanov, and R. Langer Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres Pharm. Res. 17 2000 100 106
17. I. Grizzi, S.L. Garreau, and M. Vert Hydrolytic degradation of devices based on poly(dl-lactic acid) size dependence Biomaterials 16 1995 305 311
18. J. Kang, and S.P. Schwendeman Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins Mol. Pharm. 4 2007 104 118
19. R.A. Kenley, M.O. Lee, T.R. Mahoney, and L.M. Sanders Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro Macromolecules 20 1987 2398 2403
20. D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann How porosity and size affect the drug release mechanisms from PLGA-based microparticles Int. J. Pharm. 314 2006 198 206
21. D. Klose, F. Siepmann, K. Elkharraz, and J. Siepmann PLGA-based drug delivery systems: Importance of the type of drug and device geometry Int. J. Pharm. 354 2008 95 103
22. D. Klose, F. Siepmann, J.F. Willart, M. Descamps, and J. Siepmann Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio Int. J. Pharm. 383 2010 123 131
23. J.W. Kostanski, and P.P. DeLuca A novel in vitro release technique for peptide containing biodegradable microspheres AAPS PharmSciTech. 1 2000 E4
24. L. Li, and S.P. Schwendeman Mapping neutral microclimate pH in PLGA microspheres J. Control. Release 101 2005 163 173
25. T.K. Mandal Evaluation of a novel phase separation technique for the encapsulation of water-soluble drugs in biodegradable polymer Drug Dev. Ind. Pharm. 24 1998 623 629
26. M. Martinez, M. Rathbone, D. Burgess, and M. Huynh In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting J. Control. Release 129 2008 79 87
27. M.N. Martinez, M.J. Rathbone, D. Burgess, and M. Huynh Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products J. Control. Release 142 2010 2 7
28. P. Menei, E. Jadaud, N. Faisant, M. Boisdron-Celle, S. Michalak, D. Fournier, M. Delhaye, and J.P. Benoit Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma Cancer 100 2004 405 410
29. J.C. Middleton, and A.J. Tipton Synthetic biodegradable polymers as orthopedic devices Biomaterials 21 2000 2335 2346
30. P.B. O'Donnell, and J.W. McGinity Preparation of microspheres by the solvent evaporation technique Adv. Drug Del. Rev. 28 1997 25 42
31. T.G. Park Degradation of poly(image-lactic acid) microspheres: effect of molecular weight J. Control. Release 30 1994 161 173
32. H.B. Ravivarapu, K. Burton, and P.P. DeLuca Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres Eur. J. Pharm. Biopharm. 50 2000 263 270
33. H. Sah, and Y.W. Chien Effects of H+ liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability J. Pharm. Sci. 84 1995 1353 1359
34. S.P. Sansdrap, and A.J. Moës Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(-lactide-co-glycolide) microspheres Int. J. Pharm. 98 1993 157 164
35. M. Shameem, H. Lee, and P.P. DeLuca A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations AAPS PharmSci. 1 1999 E7
36. J. Siepmann, K. Elkharraz, F. Siepmann, and D. Klose How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment Biomacromolecules 6 2005 2312 2319
37. M. Siewert, J. Dressman, C.K. Brown, and V.P. Shah FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms AAPS PharmSciTech. 4 2003 pE7
38. A.J. Thote, J.T. Chappell, R.B. Gupta, and R. Kumar Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs Drug Dev. Ind. Pharm. 31 2005 43 57
39. C. Tyrchan, N. Blomberg, O. Engkvist, T. Kogej, and S. Muresan Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds Bioorg. Med. Chem. Lett. 19 2009 6943 6947
40. L. Wu, and J. Ding In vitro degradation of three-dimensional porous poly(d,l-lactide-co-glycolide) scaffolds for tissue engineering Biomaterials 25 2004 5821 5830
41. Z. Zhou, C. Chaibundit, A. D'Emanuele, K. Lennon, D. Attwood, and C. Booth Solubilisation of drugs in worm-like micelles of block copolymers of ethylene oxide and 1,2-butylene oxide in aqueous solution Int. J. Pharm. 354 2008 82 87
42. B.S. Zolnik, P.E. Leary, and D. Burgess Elevated temperature accelerated release testing of PLGA microspheres J. Control. Release 112 2006 293 300